HFA Premium Access

Moderated Poster session 6 - Therapy

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Miscellaneous
Session type: Moderated Posters
Date: 2 May 2017
Time: 10:00 - 11:00

Congress Session

10 presentations in this session

Granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the RIGENERA trial): 10 years follow-up- FINAL RESULTS

Speaker: Doctor D. D'amario (Rome, IT)
Thumbnail

Feasibility and benefit of neurohumoral blocker uptitration following cardiac resynchronization therapy

Speaker: Doctor P. Martens (Genk, BE)
Thumbnail

Relation of biological and functional LV remodeling to obstruction in hypertrophic cardiomyopathy. A rest and exercise echocardiographic study with longitudinal strain measurement

Speaker: Professor J. Trochu (Nantes, FR)
Thumbnail

Early phase 99Tc-HMDP scintigraphy: a rapid and reliable technique for the diagnosis and typing of cardiac amyloidosis

Speaker: Professor T. Damy (Creteil, FR)
Thumbnail

Less invasive ventricular reshaping provides sustained reduction of heart failure symptoms

Speaker: Doctor M. Biffi (Bologna, IT)
Thumbnail

A natriuretic peptides clearance receptor agonist reduces pulmonary artery pressures and enhances cardiac performances: new hope for PH due to HF

Speaker: Doctor E. Eroume A Egom (Toronto, CA)
Thumbnail

Effect of aortic valve opening pattern on endothelial functions after continuous flow left ventricular assist device implantation

Speaker: Professor S. Nalbantgil (Izmir, TR)
Thumbnail

Spironolactone reduces all-cause mortality in women but not men with heart failure with preserved ejection fraction enrolled in TOPCAT from the Americas

Speaker: Assistant Professor D. Kao (Aurora, US)
Thumbnail

Intrarenal venous flow alterations during transition from euvolemia to intravascular volume expansion in heart failure patients with reduced ejection fraction

Speaker: Ms P. Nijst (Genk, BE)
Thumbnail

Therapeutic potential of phosphodiesterase 5 inhibitors in patients with heart failure with preserved ejection fraction (HFpEF) and combined post- and pre-capillary pulmonary hypertension (Cpc-PH).

Speaker: Doctor T. Kramer (Cologne, DE)
Thumbnail

10 speakers from this session

Doctor Domenico D'amario

Fondazione Policlinico Universitario A. Gemelli IRCSS, Rome (Italy)
4 presentations
0 follower

Doctor Pieter Martens

Ziekenhuis Oost Limburg, Genk (Belgium)
1 presentation
0 follower

Professor Jean-Noel Trochu

University Hospital of Nantes Laennec, Nantes (France)
5 presentations
0 follower

Professor Thibaud Damy

University Hospital Henri Mondor, Creteil (France)
21 presentations
0 follower

Doctor Mauro Biffi

S. Orsola-Malpighi Policlinic, Bologna (Italy)
26 presentations
0 follower

Doctor Emmanuel Eroume A Egom

Reflex Medical Centre, Toronto (Canada)
0 follower

Professor Sanem Nalbantgil

Ege University Hospital, Izmir (Turkey)
3 presentations
0 follower

Assistant Professor David Peter Kao

University of Colorado, Aurora (United States of America)
0 follower

Ms Petra Nijst

Hospital Oost-Limburg (ZOL), Genk (Belgium)
4 presentations
0 follower

Doctor Tilmann Kramer

Cologne University Hospital - Heart Center, Cologne (Germany)
0 follower

This platform is supported by

logo Novo Nordisk